Literature DB >> 7566349

Secreted beta-APP stimulates MAP kinase and phosphorylation of tau in neurons.

S M Greenberg1, K S Kosik.   

Abstract

We have previously demonstrated that the secreted form of the beta-amyloid precursor protein (beta-APP) activates mitogen-activated protein (MAP) kinases in PC-12 pheochromocytoma cells. beta-APP as well as other treatments that activate MAP kinase also enhance phosphorylation of the microtubule-associated protein tau in these cells. In this study, we extended this analysis to neurons. Using dissociated cultures of cortical neurons, we found that exposure to beta-APP activated MAP kinase 4 and 7 days but not 1 day after plating. Phosphorylation of tau in neurons was measured by immunoreactivity with the AT8 antibody, which recognizes a phosphorylated epitope present in tau from paired helical filaments. We found that activation of MAP kinase in neurons was associated with increased amounts of AT8-reactive tau. These results support a role for MAP kinase in transducing the biological effects of secreted beta-APP on neurons and suggest possible mechanisms by which beta-APP might be involved in the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566349     DOI: 10.1016/0197-4580(94)00172-w

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

Review 1.  Cellular models for tau filament assembly.

Authors:  Li-wen Ko; Michael DeTure; Naruhiko Sahara; Rifki Chihab; Shu-Hui Yen
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

2.  Is brain iron trafficking part of the physiology of the amyloid precursor protein?

Authors:  Danielle K Bailey; Daniel J Kosman
Journal:  J Biol Inorg Chem       Date:  2019-10-01       Impact factor: 3.358

Review 3.  Not just amyloid: physiological functions of the amyloid precursor protein family.

Authors:  Ulrike C Müller; Thomas Deller; Martin Korte
Journal:  Nat Rev Neurosci       Date:  2017-03-31       Impact factor: 34.870

4.  Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.

Authors:  E Rundén; P O Seglen; F M Haug; O P Ottersen; T Wieloch; M Shamloo; J H Laake
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

Review 5.  Cognitive enhancement therapy for Alzheimer's disease. The way forward.

Authors:  L Parnetti; U Senin; P Mecocci
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 6.  Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.

Authors:  Satyabrata Kar; Stephen P M Slowikowski; David Westaway; Howard T J Mount
Journal:  J Psychiatry Neurosci       Date:  2004-11       Impact factor: 6.186

7.  Soluble amyloid precursor protein: a novel proliferation factor of adult progenitor cells of ectodermal and mesodermal origin.

Authors:  Michael P Demars; Amelia Bartholomew; Zuzana Strakova; Orly Lazarov
Journal:  Stem Cell Res Ther       Date:  2011-08-30       Impact factor: 6.832

8.  Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50.

Authors:  Orwa Aboud; Paul A Parcon; K Mark DeWall; Ling Liu; Robert E Mrak; W Sue T Griffin
Journal:  Front Cell Neurosci       Date:  2015-03-25       Impact factor: 5.505

9.  Low Serum Phosphorus Correlates with Cerebral Aβ Deposition in Cognitively Impaired Subjects: Results from the KBASE Study.

Authors:  Jong-Chan Park; Sun-Ho Han; Min S Byun; Dahyun Yi; Jun Ho Lee; Kyua Park; Dong Young Lee; Inhee Mook-Jung
Journal:  Front Aging Neurosci       Date:  2017-11-06       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.